Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2005
10/05/2005CN1221251C Foot refreshing powder
10/05/2005CN1221246C Use of medicine having chemical compound for promoting collagen synthesizing activity
10/05/2005CN1221244C Micropigment mixture
10/05/2005CN1221238C Use of oximino-and hydroxylamino-prostaglandins
10/05/2005CN1221237C Composition for treatment of scars skin disease
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951855 vascular damaging agents
10/04/2005US6951850 Dipeptide derivatives
10/04/2005CA2262862C Angiogenic inhibitory compounds
09/2005
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005089806A1 Cream-gel containing ivermectin
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089782A1 Process for producing fermented stevia solution, health drink for livestock and udder wasiing liquor for livestock
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2004041758A8 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics
09/29/2005US20050215772 Furanone derivatives and methods of making same
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215579 consisting of lung, renal, prostate, uterine, melanoma and breast tumors; cyclodextrin inclusion compounds aid solubility
09/29/2005US20050215574 4-anilino quinazoline derivatives as antiproliferative agents
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia
09/29/2005US20050215509 Method for inhibiting jnk-1 kinase activity by SCCA
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050214391 Method and composition for the treatment of dermatologic diseases
09/29/2005US20050214384 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock
09/29/2005US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/29/2005US20050214291 Treatment method
09/29/2005US20050214270 Lactobacillus acidophilus and/or fermentum; reducing immunoglobulin E levels; safe, easy to take
09/29/2005US20050214247 Glycodendrimers having biological activity
09/29/2005DE10393402T5 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Means and Toilettenartikel- or pharmaceutical composition to accelerate the uptake of basic amino acids in cells
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560305A1 Human anti-epidermal growth factor receptor antibody
09/29/2005CA2559545A1 Tetra-cyclic carboline derivatives for inhibiting angiogenesis
09/29/2005CA2558254A1 Cream-gel containing ivermectin
09/29/2005CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols
09/29/2005CA2554637A1 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder
09/29/2005CA2553933A1 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
09/29/2005CA2553932A1 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
09/29/2005CA2553208A1 Of at use of an antagonist compound of at least one receptor selected from a group comprising beta-adrenergic receptors, a at1, 5-ht5 and galanin receptor for preparing a pharmaceutical composition for treating rosacea
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
09/28/2005EP1578433A1 Use of pothomorphe umbellata extract, composition on basis of pothomorphe umbellata extract and method of application of the pothomorphe umbellata extract
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
09/28/2005EP1439846A4 Storage-stable human fibrinogen solutions
09/28/2005EP1401438B1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1361880B1 6-substituted pyrido-pyrimidines
09/28/2005EP1320357A4 Topical polymeric antimicrobial emulsion
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1222913B1 Depilating method
09/28/2005EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1137766B1 Use of il-12 antibodies to treat psoriasis
09/28/2005EP1104294B1 Compositions and methods of treating abnormal cell proliferation
09/28/2005EP1085804A4 Method and composition for the treatment of epidermal irritations and infections
09/28/2005EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
09/28/2005CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
09/28/2005CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675220A Epothilone derivatives
09/28/2005CN1675213A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675211A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674940A Topical anhydrous and ethanol-free ascomycin compositions
09/28/2005CN1674923A Non-polymeric hematopoeitic cell clots for delivery of active agents
09/28/2005CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674919A Use of cgrp antagonist compounds for treatment of psoriasis
09/28/2005CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections
09/28/2005CN1674894A Ether substituted imidazopyridines
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674864A Topical formulation for prevention and treatment of acne
09/28/2005CN1674863A Antiaging composition
09/28/2005CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 1065